Relative Contribution of CD4+ and CD68+ Cells to the Expression of IL-4 and IL-10, Respectively, in Lesions From Pregnant and Nonpregnant Women With Cutaneous Leishmaniasis
Parameter . | Nonpregnant CL (n = 6) . | Pregnant CL (n = 7) . |
---|---|---|
Number of IL-4+ cells | 265 ± 230a | 629 ± 377a |
Number of CD4+IL-4+ cells | 126 ± 25a | 405 ± 258a |
Relative contribution of CD4+ cells to IL-4 expression | 67 ± 28 | 68 ± 18 |
Number of IL-10+ cells | 160 ± 130a | 558 ± 382a |
Number of CD68+IL-10+ cells | 56 ± 50 | 302 ± 253 |
Relative contribution of CD68+ cells to IL-10 expression | 38 ± 34 | 62 ± 23 |
Parameter . | Nonpregnant CL (n = 6) . | Pregnant CL (n = 7) . |
---|---|---|
Number of IL-4+ cells | 265 ± 230a | 629 ± 377a |
Number of CD4+IL-4+ cells | 126 ± 25a | 405 ± 258a |
Relative contribution of CD4+ cells to IL-4 expression | 67 ± 28 | 68 ± 18 |
Number of IL-10+ cells | 160 ± 130a | 558 ± 382a |
Number of CD68+IL-10+ cells | 56 ± 50 | 302 ± 253 |
Relative contribution of CD68+ cells to IL-10 expression | 38 ± 34 | 62 ± 23 |
Numbers of cells were counted based on the expression of specific fluorescent markers for either IL-4 or IL-10 alone, a combination of IL-4 and CD4 or IL-10 and CD68, as indicated and described in Methods. The relative contributions of CD4+ and CD68+ cells to IL-4 and IL-10 expression, respectively, were calculated as the percentage of CD4+ or CD68+ cells expressing each cytokine in relation to the total expression of that given cytokine.
The numbers are expressed in mean ± SD. The Relative contribution is expressed in percentage.
Abbreviation: CL, cutaneous leishmaniasis; IL, interleukin.
aStatistically significant differences between pregnant and nonpregnant CL groups, P < .05.
Relative Contribution of CD4+ and CD68+ Cells to the Expression of IL-4 and IL-10, Respectively, in Lesions From Pregnant and Nonpregnant Women With Cutaneous Leishmaniasis
Parameter . | Nonpregnant CL (n = 6) . | Pregnant CL (n = 7) . |
---|---|---|
Number of IL-4+ cells | 265 ± 230a | 629 ± 377a |
Number of CD4+IL-4+ cells | 126 ± 25a | 405 ± 258a |
Relative contribution of CD4+ cells to IL-4 expression | 67 ± 28 | 68 ± 18 |
Number of IL-10+ cells | 160 ± 130a | 558 ± 382a |
Number of CD68+IL-10+ cells | 56 ± 50 | 302 ± 253 |
Relative contribution of CD68+ cells to IL-10 expression | 38 ± 34 | 62 ± 23 |
Parameter . | Nonpregnant CL (n = 6) . | Pregnant CL (n = 7) . |
---|---|---|
Number of IL-4+ cells | 265 ± 230a | 629 ± 377a |
Number of CD4+IL-4+ cells | 126 ± 25a | 405 ± 258a |
Relative contribution of CD4+ cells to IL-4 expression | 67 ± 28 | 68 ± 18 |
Number of IL-10+ cells | 160 ± 130a | 558 ± 382a |
Number of CD68+IL-10+ cells | 56 ± 50 | 302 ± 253 |
Relative contribution of CD68+ cells to IL-10 expression | 38 ± 34 | 62 ± 23 |
Numbers of cells were counted based on the expression of specific fluorescent markers for either IL-4 or IL-10 alone, a combination of IL-4 and CD4 or IL-10 and CD68, as indicated and described in Methods. The relative contributions of CD4+ and CD68+ cells to IL-4 and IL-10 expression, respectively, were calculated as the percentage of CD4+ or CD68+ cells expressing each cytokine in relation to the total expression of that given cytokine.
The numbers are expressed in mean ± SD. The Relative contribution is expressed in percentage.
Abbreviation: CL, cutaneous leishmaniasis; IL, interleukin.
aStatistically significant differences between pregnant and nonpregnant CL groups, P < .05.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.